Tri Locum Partners LP Teva Pharmaceutical Industries LTD Transaction History

Tri Locum Partners LP

$433 Million
Q4 2024

A detailed history of Tri Locum Partners LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Tri Locum Partners LP holds 2,423,116 shares of TEVA stock, worth $41.6 Million. This represents 12.33% of its overall portfolio holdings.

Number of Shares

2,423,116

Previous 2,755,737 12.07%

Holding current value

$41.6 Million

Previous $49.7 Million 7.55%

% of portfolio

12.33%

Previous 13.26%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$16.43 - $22.77 $5.46 Million - $7.57 Million	-332,621 Reduced 12.07%	2,423,116 $53.4 Million
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $3.25 Million - $3.89 Million	205,430 Added 8.06%	2,755,737 $49.7 Million
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $4.27 Million - $5.81 Million	334,119 Added 15.08%	2,550,307 $41.4 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $4.5 Million - $6.09 Million	421,853 Added 23.51%	2,216,188 $31.3 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $6.81 Million - $8.91 Million	-838,558 Reduced 31.85%	1,794,335 $18.7 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $11.4 Million - $16.3 Million	1,527,123 Added 138.1%	2,632,893 $26.9 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $672,458 - $884,469	93,397 Added 9.23%	1,105,770 $8.33 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $8.46 Million - $11.5 Million	1,012,373 New	1,012,373 $8.96 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $4.69 Million - $8.17 Million	683,613 New	683,613 $5.52 Million

Others Institutions Holding TEVA

# of Institutions

673

Shares Held

578M

Call Options Held

25.5M

Put Options Held

14.7M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Account

Tri Locum Partners LP Teva Pharmaceutical Industries LTD Transaction History